$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
02:00pm, Sunday, 07'th Apr 2024
Looking ahead, the future of the U.S. economy appears promising despite ongoing challenges. President Biden's efforts to steer the economy through inflation concerns are showing strong results.
Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:51pm, Friday, 05'th Apr 2024
Merck (MRK) concluded the recent trading session at $127.99, signifying a +0.26% move from its prior day's close.
Merck (MRK) Begins Phase III NSCLC Study on KRAS Candidate
06:36am, Friday, 05'th Apr 2024
Merck's (MRK) phase III study will evaluate KRAS G12C inhibitor candidate MK-1084 for first-line treatment of certain patients with metastatic NSCLC.
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug
06:41am, Thursday, 04'th Apr 2024
Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian cancer.
3 Dow Jones Stocks For Your April 2024 Watch List
10:33am, Wednesday, 03'rd Apr 2024
Here are 3 Dow Jones stocks to watch in the stock market today.
Merck: Better Times Ahead On Approvals And Outlook
04:39pm, Tuesday, 02'nd Apr 2024
After a forgettable last year, Merck & Co., Inc.'s stock price is up 20% YTD, supported by approvals, a positive outlook for 2024, and an attractive forward P/E. Keytruda, the company's top-selling tr
After A 30% Fall In A Year Is Pfizer Stock A Better Pick Over Merck?
07:00am, Tuesday, 02'nd Apr 2024
Given its attractive valuation, we believe Pfizer stock (NYSE: PFE) is a better pick than its peer — Merck stock (NYSE: MRK). MRK trades at a higher valuation multiple of 5.6x revenues vs.
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
10:56am, Monday, 01'st Apr 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
10:51am, Friday, 29'th Mar 2024
As the number of grey-haired people rises worldwide, investors need to notice the strong-buy healthcare stocks. The need for healthcare will grow as the number of people aged 60 years and older dou
Merck (MRK) Rises Higher Than Market: Key Facts
06:56pm, Thursday, 28'th Mar 2024
Merck (MRK) reachead $131.95 at the closing of the latest trading day, reflecting a +0.15% change compared to its last close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Thursday, 28'th Mar 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Three-Stock Lunch: Tesla, Merck, and RH
03:43pm, Wednesday, 27'th Mar 2024
Jerry Castellini, Castle Ark Management president and CIO, joins 'Power Lunch' to discuss Castellini's investing take on three stocks: Tesla, Merck, and RH.
Merck shares move higher as lung disorder drug secures ‘squeaky clean' label from FDA
10:32am, Wednesday, 27'th Mar 2024
Merck & Co Inc (NYSE:MRK, ETR:6MK) shares traded more than 4% higher after it won US Food and Drug Administration (FDA) approval for its lung disorder drug sotatercept, brand name WINREVAIR. After b
Merck Stock Nabs Record High After FDA Approval
10:19am, Wednesday, 27'th Mar 2024
Merck & Co Inc (NYSE:MRK) was last seen up 4.4% to trade at $130.99, after the Food and Drug Administration (FDA) approved its Winrevair treatment for adults with high blood pressure due to constri
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
10:05am, Wednesday, 27'th Mar 2024
Zacks.com users have recently been watching Merck & Co. (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Sign In
Buy MRK